IPRATROPIUM BROMIDE

Ipratropium Bromide Adverse Events Reported to the FDA Over Time

How are Ipratropium Bromide adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ipratropium Bromide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ipratropium Bromide is flagged as the suspect drug causing the adverse event.

Most Common Ipratropium Bromide Adverse Events Reported to the FDA

What are the most common Ipratropium Bromide adverse events reported to the FDA?

Drug Ineffective	965 (6.11%)
Dyspnoea	941 (5.96%)
Dysgeusia	366 (2.32%)
Pneumonia	302 (1.91%)
Cough	272 (1.72%)
Death	240 (1.52%)
Chronic Obstructive Pulmonary Disea...	231 (1.46%)
Dizziness	185 (1.17%)
Asthma	180 (1.14%)
Drug Effect Decreased	164 (1.04%)
Condition Aggravated	129 (.82%)
	Show More
Chest Pain	126 (.8%)
Throat Irritation	118 (.75%)
Headache	117 (.74%)
Nausea	111 (.7%)
Tremor	111 (.7%)
Chest Discomfort	109 (.69%)
Wheezing	103 (.65%)
Dysphonia	99 (.63%)
Dry Mouth	98 (.62%)
Bronchitis	95 (.6%)
Respiratory Failure	94 (.6%)
Medication Error	93 (.59%)
Feeling Abnormal	91 (.58%)
Malaise	89 (.56%)
Tachycardia	89 (.56%)
Asthenia	87 (.55%)
Atrial Fibrillation	79 (.5%)
Heart Rate Increased	79 (.5%)
Cardiac Failure Congestive	76 (.48%)
Fatigue	76 (.48%)
Lung Infection	74 (.47%)
Rash	70 (.44%)
Oropharyngeal Pain	69 (.44%)
Overdose	69 (.44%)
Insomnia	68 (.43%)
Burning Sensation	64 (.41%)
Lung Neoplasm Malignant	64 (.41%)
Blood Pressure Increased	62 (.39%)
Confusional State	62 (.39%)
Dyspnoea Exertional	61 (.39%)
Vision Blurred	61 (.39%)
Therapeutic Response Decreased	60 (.38%)
Loss Of Consciousness	57 (.36%)
Myocardial Infarction	57 (.36%)
Palpitations	56 (.35%)
Oedema Peripheral	55 (.35%)
Drug Interaction	53 (.34%)
Hypertension	52 (.33%)
Oxygen Saturation Decreased	50 (.32%)
Pulmonary Congestion	49 (.31%)
Pyrexia	49 (.31%)
Cardiac Arrest	47 (.3%)
Constipation	47 (.3%)
Fall	47 (.3%)
Hypersensitivity	47 (.3%)
Incorrect Dose Administered	47 (.3%)
Increased Upper Airway Secretion	47 (.3%)
Bronchospasm	46 (.29%)
Emphysema	46 (.29%)
Lung Disorder	45 (.28%)
Productive Cough	45 (.28%)
Vomiting	45 (.28%)
Cardiac Failure	44 (.28%)
Glossodynia	44 (.28%)
Hyperhidrosis	44 (.28%)
Oral Discomfort	44 (.28%)
Respiratory Distress	44 (.28%)
Blood Glucose Increased	43 (.27%)
Urticaria	42 (.27%)
Nasopharyngitis	41 (.26%)
Anxiety	40 (.25%)
Convulsion	40 (.25%)
Cyanosis	40 (.25%)
Pruritus	40 (.25%)
Weight Decreased	40 (.25%)
Epistaxis	38 (.24%)
Pulmonary Embolism	38 (.24%)
Urinary Retention	38 (.24%)
Inflammation	37 (.23%)
Muscle Spasms	37 (.23%)
Transient Ischaemic Attack	37 (.23%)
Cardiac Disorder	36 (.23%)
Cerebrovascular Accident	36 (.23%)
Dehydration	36 (.23%)
Pharyngeal Oedema	36 (.23%)
Respiratory Tract Irritation	36 (.23%)
Throat Tightness	36 (.23%)
Diarrhoea	35 (.22%)
Nervousness	35 (.22%)
Product Quality Issue	35 (.22%)
Depressed Level Of Consciousness	34 (.22%)
Drug Exposure During Pregnancy	34 (.22%)
General Physical Health Deteriorati...	34 (.22%)
Hypoaesthesia	34 (.22%)
Pupils Unequal	34 (.22%)
Mesothelioma	33 (.21%)
Mydriasis	33 (.21%)
Nasal Congestion	33 (.21%)
Pain	33 (.21%)
Rhinorrhoea	32 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ipratropium Bromide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ipratropium Bromide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ipratropium Bromide

What are the most common Ipratropium Bromide adverse events reported to the FDA?

Respiratory	2326 (14.73%)
Therapeutic And Nontherapeutic Effe...	1329 (8.41%)
Neurological	1038 (6.57%)
Infections - Pathogen Unspecified	796 (5.04%)
Bronchial Disorders	613 (3.88%)
Cardiac Arrhythmias	389 (2.46%)
Gastrointestinal Signs	367 (2.32%)
Medication Errors	352 (2.23%)
Epidermal And Dermal Conditions	318 (2.01%)
Cardiac And Vascular Investigations	273 (1.73%)
Fatal Outcomes	252 (1.6%)
	Show More
Oral Soft Tissue Conditions	200 (1.27%)
Movement Disorders	199 (1.26%)
Lower Respiratory Tract Disorders	187 (1.18%)
Upper Respiratory Tract Disorders	179 (1.13%)
Metabolic, Nutritional And Blood Ga...	148 (.94%)
Cardiac Disorder Signs	138 (.87%)
Anxiety Disorders	137 (.87%)
Injuries	136 (.86%)
Heart Failures	132 (.84%)
Headaches	131 (.83%)
Urinary Tract Signs	125 (.79%)
Gastrointestinal Motility And Defec...	121 (.77%)
Allergic Conditions	119 (.75%)
Musculoskeletal And Connective Tiss...	119 (.75%)
Vision	112 (.71%)
Muscle	107 (.68%)
Tongue Conditions	105 (.66%)
Salivary Gland Conditions	103 (.65%)
Coronary Artery	100 (.63%)
Electrolyte And Fluid Balance Condi...	99 (.63%)
Physical Examination Topics	99 (.63%)
Respiratory And Mediastinal Neoplas...	99 (.63%)
Deliria	96 (.61%)
Sleep Disorders	96 (.61%)
Skin Appendage Conditions	94 (.6%)
Bacterial Infectious	92 (.58%)
Ocular Neuromuscular	89 (.56%)
Bone And Joint Injuries	88 (.56%)
Central Nervous System Vascular	83 (.53%)
Product Quality Issues	80 (.51%)
Dental And Gingival Conditions	79 (.5%)
Chemical Injury And Poisoning	73 (.46%)
Fungal Infectious	71 (.45%)
Eye	70 (.44%)
Renal Disorders	70 (.44%)
Angiedema And Urticaria	58 (.37%)
Mental Impairment	57 (.36%)
Procedural And Device Related Injur...	57 (.36%)
Appetite And General Nutritional	56 (.35%)
Body Temperature Conditions	55 (.35%)
Cardiac Valve	55 (.35%)
Glucose Metabolism Disorders	55 (.35%)
Ocular Infections, Irritations And ...	55 (.35%)
Pulmonary Vascular	53 (.34%)
Vascular Hypertensive	52 (.33%)
Joint	51 (.32%)
Hematology Investigations	49 (.31%)
Acid-base	48 (.3%)
Viral Infectious	47 (.3%)
Toxicology And Therapeutic Drug Mon...	44 (.28%)
Lifestyle Issues	43 (.27%)
Seizures	42 (.27%)
Cranial Nerve Disorders	41 (.26%)
Respiratory And Pulmonary Investiga...	41 (.26%)
Depressed Mood Disorders	40 (.25%)
Encephalopathies	39 (.25%)
White Blood Cell	39 (.25%)
Disturbances In Thinking	36 (.23%)
Hepatic And Hepatobiliary	36 (.23%)
Mesotheliomas	36 (.23%)
Vascular	36 (.23%)
Myocardial	35 (.22%)
Hepatobiliary	34 (.22%)
Decreased And Nonspecific Blood Pre...	30 (.19%)
Lipid Analyses	29 (.18%)
Platelet	29 (.18%)
Pleural	29 (.18%)
Gastrointestinal Hemorrhages	28 (.18%)
Peripheral Neuropathies	28 (.18%)
Psychiatric	28 (.18%)
Anemias Nonhemolytic And Marrow Dep...	27 (.17%)
Glaucoma And Ocular Hypertension	27 (.17%)
Water, Electrolyte And Mineral	27 (.17%)
Anterior Eye Structural Change, Dep...	26 (.16%)
Fetal Complications	26 (.16%)
Miscellaneous And Site Unspecified ...	26 (.16%)
Bone Disorders	24 (.15%)
Breast Neoplasms Malignant And Unsp...	24 (.15%)
Musculoskeletal And Connective Tiss...	24 (.15%)
Renal And Urinary Tract Investigati...	24 (.15%)
Therapeutic Procedures And Supporti...	24 (.15%)
Suicidal And Self-injurious Behavio...	22 (.14%)
Manic And Bipolar Mood Disorders	20 (.13%)
Exocrine Pancreas Conditions	19 (.12%)
Gastrointestinal Conditions	19 (.12%)
Inner Ear And Viiith Cranial Nerve	19 (.12%)
Administration Site Reactions	18 (.11%)
Arteriosclerosis, Stenosis, Vascula...	18 (.11%)
Thyroid Gland	18 (.11%)
Hemolyses And Related Conditions	17 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ipratropium Bromide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ipratropium Bromide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.